Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated with Rivaroxaban and Warfarin in the ROCKET AF Trial

被引：0
|
作者：
Piccini, Jonathan P. [1 ]
Stevens, Susanna [1 ]
Lokhnygina, Yuliya [1 ]
Patel, Manesh [1 ]
Singer, Daniel [2 ]
Halperin, Jonathan [3 ]
Hankey, Graeme [4 ]
Hacke, Werner [5 ]
Becker, Richard [1 ]
Nessel, Christopher [6 ]
Mahaffey, Kenneth [1 ]
Fox, Keith [7 ]
Califf, Robert [1 ]
Breithardt, Gunter [8 ]
机构：
[1] Duke Univ, Med Ctr, Duke Clin Rsch Inst, Durham, NC USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Mt Sinai Med Ctr, New York, NY 10029 USA
[4] Royal Perth Hosp, Perth, WA 6001, Australia
[5] Heidelberg Univ, Heidelberg, Germany
[6] Johnson & Johnson Pharmaceut Rsch & Dev, Raritan, NJ USA
[7] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[8] Hosp Univ Munster, Munster, Germany
来源：
CIRCULATION | 2012年 / 126卷 / 21期
关键词：
Atrial fibrillation; Ablation; Anticoagulaion;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19281
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Bleeding in patientswith atrial fibrillation treated with dabigatran, rivaroxaban or warfarin
    Kawada, Tomoyuki
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 38 : E20 - E20
  • [42] Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation
    Sherwood, Matthew W.
    Douketis, James D.
    Patel, Manesh R.
    Piccini, Jonathan P.
    Hellkamp, Anne S.
    Lokhnygina, Yuliya
    Spyropoulos, Alex C.
    Hankey, Graeme J.
    Singer, Daniel E.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Fox, Keith A. A.
    Califf, Robert M.
    Becker, Richard C.
    CIRCULATION, 2014, 129 (18) : 1850 - 1859
  • [43] CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: EXPERIENCE FROM THE ROCKET AF TRIAL
    Breithardt, Guenter
    Baumgartner, Helmut
    Berkowitz, Scott
    Hellkamp, Anne
    Piccini, Jonathan
    Stevens, Susanna
    Lokhnygina, Yuliya
    Patel, Manesh
    Halperin, Jonathan
    Singer, Daniel
    Hankey, Graeme
    Hacke, Werner
    Becker, Richard
    Nessel, Christopher
    Mahaffey, Kenneth
    Fox, Keith
    Califf, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E282 - E282
  • [44] Evaluation of clinical outcomes among nonvalvular atrial fibrillation patients treated with rivaroxaban or warfarin, stratified by renal function
    Weir, Matthew R.
    Haskell, Lloyd
    Berger, Jeffrey S.
    Ashton, Veronica
    Laliberte, Francois
    Crivera, Concetta
    Brown, Kip
    Lefebvre, Patrick
    Schein, Jeffrey
    CLINICAL NEPHROLOGY, 2018, 89 (05) : 314 - 329
  • [45] Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF
    Jones, W. S.
    Hellkamp, A. S.
    Halperin, J.
    Piccini, J. P.
    Breithardt, G.
    Singer, D. E.
    Fox, K. A. A.
    Mahaffey, K. W.
    Califf, R. M.
    Patel, M. R.
    EUROPEAN HEART JOURNAL, 2013, 34 : 809 - 810
  • [46] Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF
    Jones, William Schuyler
    Hellkamp, Anne S.
    Halperin, Jonathan
    Piccini, Jonathan P.
    Breithardt, Gunter
    Singer, Daniel E.
    Fox, Keith A. A.
    Hankey, Graeme J.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Patel, Manesh R.
    EUROPEAN HEART JOURNAL, 2014, 35 (04) : 242 - 249
  • [47] Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial
    Cohen, Ariel A.
    Heidbuchel, Hein
    Le Heuzey, Jean-Yves
    De Caterina, Raffaele
    Merino, Jose L.
    Jin, James
    Winters, Shannon M.
    Goette, Andreas
    Lip, Gregory Y. H.
    AMERICAN HEART JOURNAL, 2019, 209 : 131 - 135
  • [48] Atrial Fibrillation Radiofrequency Ablation on Uninterrupted Anticoagulation with Rivaroxaban Versus Warfarin
    Mendoza, Ivan
    Reina, Janet
    Baez-Escudero, Jose
    Helguera, Marcelo E.
    Pinski, Sergio L.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2014, 25 (05) : 560 - 560
  • [49] Outcomes following cardioversion for patients with cardiac amyloidosis and atrial fibrillation or atrial flutter
    Loungani, Rahul S.
    Rehorn, Michael R.
    Geurink, Kyle R.
    Coniglio, Amanda C.
    Black-Maier, Eric
    Pokorney, Sean D.
    Khouri, Michel G.
    AMERICAN HEART JOURNAL, 2020, 222 : 26 - 29
  • [50] Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
    Halperin, Jonathan L.
    Hankey, Graeme J.
    Wojdyla, Daniel M.
    Piccini, Jonathan P.
    Lokhnygina, Yuliya
    Patel, Manesh R.
    Breithardt, Guenter
    Singer, Daniel E.
    Becker, Richard C.
    Hacke, Werner
    Paolini, John F.
    Nessel, Christopher C.
    Mahaffey, Kenneth W.
    Califf, Robert M.
    Fox, Keith A. A.
    CIRCULATION, 2014, 130 (02) : 138 - U45
12345